"We are thrilled to welcome the Envision team to the UBC family," says Ethan Leder, CEO of UBC. "Like UBC," Leder continues, "Envision combines strategically driven scientific and technology solutions for life sciences clients. Given the increasing demand of regulators and public opinion for transparency in research, Envision's contribution to the production of objective, scientifically driven medical publications is a cornerstone of our evidence-based credo and highly valuable to the entire medical community."
"Joining UBC helps us achieve our vision of bringing a more robust scientific offering to our clients faster than we could have on our own, with people of a similar mindset," notes Brian Hepburn, Envision Co-founder and General Manager.
"UBC's mission to build all of its services with a focus on evidence made UBC an ideal partner for Envision," says Dan Donovan, Envision Co-founder and Senior Vice President of Strategy and Market Development. Donovan adds, "Envision's mission is built around the notion that products developed with a solid evidence base will deliver the greatest impact and success for all stakeholders, from industry to healthcare and insurance providers, governments and patients."
Envision Pharma is an innovative scientific communications and technology company providing commercially focused, strategically driven scientific and technology solutions to the pharmaceutical, biotechnology and device industries. Envision specializes in data dissemination and the effective application of smart technology. For further information on Envision Pharma visit http://www.envisionpharma.com .
United BioSource Corporation (UBC) is a global pharmaceutical services
organization that helps emerging and established life science companies
develop and commercialize medical products. UBC specializes in providing
new and innovative ways to study drugs
|SOURCE United BioSource Corporation|
Copyright©2008 PR Newswire.
All rights reserved